You are here

Article info

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
511 T cell-instructed inflammation drives immune checkpoint inhibitor therapy resistance
Free

Authors

  • Nam Woo Cho Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Sophia Guldberg Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Eun Ji Kim Unaffiliated, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Kamir Hiam-Galvez Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Katherine Wai Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Lauren Levine Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Rachel DeBarge Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Jacqueline Yee Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Naa Ashitey Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles
  • Matthew Spitzer Helen Diller Family Comprehensive Cancer Center, Parker Institute for Cancer Immunotherapy, Chan Zuckerberg Biohub, University of California, San Francisco, San Francisco, CA, United States PubMed articlesGoogle scholar articles

Citation

Cho NW, Guldberg S, Kim EJ, et al
511 T cell-instructed inflammation drives immune checkpoint inhibitor therapy resistance
Journal for ImmunoTherapy of Cancer 2022;10:doi: 10.1136/jitc-2022-SITC2022.0511

Publication history

  • First published November 7, 2022.
Online issue publication 
April 26, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.